Gland Pharma Limited
GLAND
Rankning i aktier
#3236
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Aktiekurs
$33.33
Senast synkroniserad: 2026-10-19
Marknadsvärde
$5.50B
Förändring (1 dag)
-0.68%
Förändring (1 år)
52.16%
Land
IN
Handel Gland Pharma Limited (GLAND)
Kategori
Healthcare
EPS för Gland Pharma Limited (GLAND)
EPS per June 2026 TTM: $0.76
Enligt Gland Pharma Limiteds senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $0.76. Vid slutet av 2024 hade bolaget ett EPS på $0.56, en minskning jämfört med EPS från 2023 som var $0.58.
EPS-historik för Gland Pharma Limited från 2017 till 2026
EPS vid slutet av varje år
| År | EPS | Ändra |
|---|---|---|
| 2026 (TTM) | $0.76 | 51.22% |
| 2025 | $0.50 | -11.86% |
| 2024 | $0.56 | -2.56% |
| 2023 | $0.58 | -40.63% |
| 2022 | $0.97 | 12.85% |
| 2021 | $0.86 | 30.13% |
| 2020 | $0.66 | 57.68% |
| 2019 | $0.42 | 31.96% |
| 2018 | $0.32 | -22.71% |
| 2017 | $0.41 | 0.00% |
EPS för liknande företag eller konkurrenter
| Företag | EPS | EPS-differens | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -26.43% |
IN
|
